Earnings: Page 2

  • A headshot of ResMed CEO Mick Farrell.
    Image attribution tooltip
    Permission granted by ResMed

    ResMed quarterly revenue beats estimates as supply chain woes ease

    Demand for CPAP devices and respirators remains strong as the company expects to pick up additional market share from rival Philips, and demand grows for its medical SaaS products.

    By Jan. 27, 2023
  • Image attribution tooltip
    VCG / Stringer via Getty Images

    Intuitive Q4 profit slips on costs to boost share of robotic surgery market

    The investment in innovation comes as Intuitive tries to maintain its dominant position in the face of rivals including Johnson & Johnson and Medtronic.

    By Jan. 25, 2023
  • 3M headquarters in Minnesota
    Image attribution tooltip

    Courtesy of 3M.

    3M’s healthcare unit Q4 earnings drop on nurse shortages, falling hospital budgets

    Elective healthcare procedure volumes were about 90% of pre-COVID levels.

    By Jan. 25, 2023
  • Band-Aid box
    Image attribution tooltip
    Courtesy of Johnson&Johnson

    J&J sees Abiomed adding to revenue in 2024; Q4 sales drop

    Foreign-exchange fluctuations helped curb revenue in the period.

    By Jan. 24, 2023
  • People walk through the lobby of the Westin St. Francis in San Francisco on Jan. 10, 2023
    Image attribution tooltip
    Jacob Bell/MedTech Dive

    Medtech companies start 2023 on ‘optimistic’ note amid earnings forecasts, staffing: J.P. Morgan

    Executive comments at the healthcare conference in San Francisco suggest companies expect staffing pressures and supply constraints to improve in 2023, analysts say.

    By Jan. 17, 2023
  • Intuitive Surgical da Vinci robot, surgeon at surgeon console
    Image attribution tooltip
    Courtesy of Intuitive Surgical

    Intuitive forecasts 12%-16% growth in procedures in 2023 even as da Vinci robot sales slowed in Q4

    For hospitals that have been reporting growth in robotic procedures, “da Vinci is a relative priority in their capital budgets,” the company said.

    By Jan. 11, 2023
  • a lab worker with testubes of blood
    Image attribution tooltip
    Courtesy of GuardantHealth

    Guardant Health posts revenue growth in Q4 on higher clinical testing volumes

    The oncology diagnostics company’s preliminary results beat analyst estimates.

    By Jan. 10, 2023
  • The Dexcom G7 Continuous Glucose Monitoring (CGM) System
    Image attribution tooltip
    Courtesy of Dexcom

    Dexcom forecasts 2023 revenue to rise as much as 20% on G7 launch

    Sales are expected to reach $3.35 billion to $3.49 billion for the full year.

    By Jan. 9, 2023
  • Team of surgeons operating on patient in hospital - stock photo Four doctors in hospital operating room with patient lying on operating table. Surgical lights shining on medical team performing operat
    Image attribution tooltip
    Johnny Greig via Getty Images

    The 10 biggest medtech stories of 2022

    MedTech Dive reporting this year has explored how companies maintained momentum even amid supply shortages and rising inflation rates.

    By MedTech Dive staff • Dec. 3, 2022
  • A stock image of a calculator alongside financial numbers
    Image attribution tooltip
    atiatiati via Getty Images

    Teleflex launches another round of restructuring

    Rising costs are pushing the device maker to incur restructuring liabilities of $31 million to $40 million.

    By Nov. 23, 2022
  • Mazor robotic system
    Image attribution tooltip
    Permission granted by Medtronic

    Medtronic lowers full-year forecast, citing drop in procedure growth

    A slower-than-expected recovery in certain procedures, including TAVR and spinal cord stimulation, curbed quarterly profit and revenue.

    By Nov. 22, 2022
  • a picture of a red stethoscope on top of a US billed money.
    Image attribution tooltip
    Adeline Kon/Healthcare Dive/MedTech Dive

    Q3 Earnings Wrap: Bumpy time for medtech with inflation, FX, supply woes

    Macroeconomic pressures were a persistent theme for the industry, with workforce reductions a part of the fallout for some companies.

    By Nov. 21, 2022
  • Becton Dickinson logo
    Image attribution tooltip
    Permission granted by Becton Dickinson

    BD says inflationary pressures persist; COVID-19 test sales plunge

    Revenue at the company’s medical segment grew in the fourth quarter, helped by the acquisition of pharmacy automation company Parata. 

    By Nov. 10, 2022
  • Persons in physician garb standing around Siemens Cios Spin Endobronchial imaging machine
    Image attribution tooltip
    Retrieved from Siemsens Website on July 01, 2022

    Siemens Healthineers beats sales forecasts on imaging demand as diagnostic pressures prompt restructuring

    Siemens Healthineers is revamping its diagnostics unit after concluding that “external headwinds [are] outweighing operational improvements.”

    By Nov. 9, 2022